-
Hospitalization for Respiratory Tract Infections Increase the Use of Medical Care and Long-Term Care Services: A Pre-Post Assessment Adopting Difference-in-Differences Analysis on LIFE Study Data
Mar 10, 2025, 14:00 PM -
Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D
Mar 10, 2025, 14:00 PM -
The Trajectory of Ground Glass Nodule Patients in China: A Real-World Perspective
Mar 10, 2025, 14:00 PM -
How is Patient Safety Addressed in Pharmacy Degree Programs in Brazil?
Mar 10, 2025, 14:00 PM -
Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany
Mar 10, 2025, 14:00 PM -
Time to Access Trends of Pharmaceutical Products in EU4 and UK (2019-2021)
Mar 10, 2025, 14:00 PM -
Assessing Risdiplam Cost-Effectiveness for Spinal Muscular Atrophy Types I, II, and III in Chile
Mar 10, 2025, 14:00 PM -
Cost Effectiveness Analysis of a Pharmacist-Led Clinical Decision Support System Powered by Machine Learning to Reduce Drug-Associated Acute Kidney Injury in the Adult Non-ICU Setting
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Overall Survival (OS) of Patients With Metastatic Triple-Negative Breast Cancer (mTNBC) in Canada
Mar 10, 2025, 14:00 PM -
Exploring the Landscape of Patient-Reported Outcomes in PCOS Clinical Trials
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Experienced Patients with T2D
Mar 10, 2025, 14:00 PM -
Healthcare Resource Optimization of Different Formulations: Daratumumab SC Compared To Daratumumab IV for Treating Multiple Myeloma
Mar 10, 2025, 14:00 PM -
Analysis of Public Expenditure of Pharmaceutical Utilization of Female Infertility in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
Payer Perspectives on ICER Evidence Reports: InsightsInto Utility for Coverage and Formulary Decision-Making
Mar 10, 2025, 14:00 PM -
Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review
Mar 10, 2025, 14:00 PM -
Assessment of Cytomegalovirus Status and Risk Stratification in Renal Transplant Recipients in Mexico: A Real-World Study
Mar 10, 2025, 14:00 PM -
Evaluating the Budget Impact of an Intrauterine Device for Postpartum Hemorrhage Management: A Hospital Perspective
Mar 10, 2025, 14:00 PM -
Indirect Treatment Comparison for Early Efficacy of VMAT2 Inhibitors for Tardive Dyskinesia and Chorea Associated with Huntington's Disease
Mar 10, 2025, 14:00 PM -
Comparative Effectiveness of Powered Surgical Stapling in Patients Undergoing Minimally Invasive Thoracic Surgery
Mar 10, 2025, 14:00 PM